# Pleurodesis Using Hypertonic Glucose

> **NCT06293885** · PHASE2 · UNKNOWN · sponsor: **London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's** · enrollment: 40 (estimated)

## Conditions studied

- Air Leak From Lung

## Interventions

- **DRUG:** Dextrose 50
- **OTHER:** Standard of Care - No Dextrose 50

## Key facts

- **NCT ID:** NCT06293885
- **Lead sponsor:** London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2024-03-30
- **Primary completion:** 2025-04-30
- **Final completion:** 2025-04-30
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2024-03-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06293885

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06293885, "Pleurodesis Using Hypertonic Glucose". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06293885. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*